Medtronic Short-Term Investments increased by 2.7% to $7.24B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $6.68B to $7.24B. Over 4 years (FY 2021 to FY 2025), Short-Term Investments shows relatively stable performance with a -1.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.
Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...
Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.
short_term_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.59B | $7.77B | $7.74B | $6.86B | $6.73B | $6.60B | $6.62B | $6.42B | $6.54B | $6.42B | $6.70B | $6.72B | $6.53B | $6.60B | $6.68B | $6.75B | $6.85B | $7.05B | $7.24B |
| QoQ Change | — | +2.3% | -0.3% | -11.4% | -1.8% | -1.9% | +0.2% | -3.0% | +1.9% | -1.7% | +4.3% | +0.3% | -2.8% | +1.0% | +1.3% | +1.0% | +1.5% | +2.9% | +2.7% |
| YoY Change | — | — | — | — | -11.3% | -15.0% | -14.5% | -6.5% | -2.9% | -2.7% | +1.2% | +4.8% | -0.1% | +2.7% | -0.2% | +0.4% | +4.8% | +6.8% | +8.3% |